American Urogynecologic Society (AUGS) Coding Webinar Series

News
Article

There are several new CPT codes for 2024, including Category III codes for tibial nerve stimulation and other changes to codes in the treatment of urinary incontinence.

Understanding 2024 Coding Changes and New Urogynecologic CPT and HCPCS Codes

This webinar series will focus on vital changes impacting your reimbursement in 2024 including a detailed exploration of the new CPT and HCPCS codes, including Category III codes for Tibial Nerve Stimulation, and other changes to codes in the treatment of urinary incontinence. Join the AUGS Coding and Reimbursement Committee for a detailed exploration of the new CPT and HCPCS codes and high-level review of all pertinent billing changes in 2024.

Registration Fee

  • AUGS Members: $95
  • Non-Members: $145

Registration fees include access to both webinars in the series. A recording will be available for those who are unable to attend the live webinars. Register today!

Webinar Part 1: New 2024 Urogynecologic CPT codes and HCPCS codes - Best Practices for Accurate Reimbursement

Wednesday, February 7, 7:00 – 8:00 pm ET

Speaker: Mark Painter | Physician Reimbursement Systems (PRS) Consulting / AUGS Coding Today

Moderator: Doug Thompson, MD | Chair, AUGS Coding and Reimbursement Committee | Texas Tech University Health Science Center

There are several new CPT codes for 2024, including Category III codes for Tibial Nerve Stimulation and other changes to codes in the treatment of urinary incontinence. During this webinar, we will explore these new Category III codes and provide guidance on appropriate documentation and associated reimbursement pathways, along with how to work with Medicare and other payers when billing. This webinar is supported by an Independent Medical Education Grant from BlueWind Medical.

Topics include:

  1. How to document and bill a Category III code to payers, including where to go for physician payment information and how to work with the payer to obtain coverage for a service with a Category III code.
  2. Documentation for new patient management CPT Codes issued by Medicare as they continue to shift reimbursement to focus on long term patient relationships and preventive healthcare.
  3. Preview of other relevant 2024 code changes that will be discussed more in-depth during Part 2.

Webinar Part 2: Coding for Your Urogynecology Practice: Surgical and Office-based Procedures

Wednesday, February 28, 7:00 – 8:00 pm ET (tentative)

Speaker: Mark Painter | Physician Reimbursement Systems (PRS) Consulting / AUGS Coding Today

Moderator: Jameca Price, MD | Vice Chair, AUGS Coding and Reimbursement Committee | The University of Oklahoma-Tulsa

This specialized session covers the intricacies of the new G2211 and pelvic exam add-on code for billing by urogynecologists. We will review real world scenarios providing practical solutions and facilitating a dynamic Q&A session. Whether you're a seasoned coder or new to the field, this session is designed to enhance your proficiency, ensuring precise representation of services described by new 2024 CPT codes. Participants will have the opportunity to have their coding questions answered.

AUGS Coding and Reimbursement Committee: Doug Thompson (Chair), Jameca Price (Vice Chair), Board Liaison: Matt Barker, Rebecca Batladen, Ashley Carroll, Sarah Collins, Yanghee Courbron, Jessica Harroche, Fareesa Kahn, Mamta Mamik, Stephanie Molden, Gnankang Napoe, Mitch Schuster, Nemi Shah, Azin Shahryarinejad, Mitch Schuster (Advisor), Marc Toglia (Advisor), Scott Poehlmann (Advisor)

Related Videos
Anne M. Suskind, MD, MS, FACS, FPMRS, answers a question during a Zoom video interview
Raveen Syan, MD, FPMRS, answers a question during a Zoom video interview
African American doctor having headache while reading an e-mail on laptop | Image Credit: © Drazen - stock.adobe.com
Man talking with a doctor on a tablet | Image Credit: © JPC-PROD - stock.adobe.com
Blur image of hospital corridor | Image Credit: © zephyr_p - stock.adobe.com
Related Content
© 2024 MJH Life Sciences

All rights reserved.